Table 1 |
||
|
the clinical features of MPS II patients and their leukocyte IDS activity |
||
|
Features |
Family 1 |
|
|
|
||
|
Patient 1 |
Patient 2 |
|
|
|
||
|
MPS II genotype |
p.R88P |
p.R88P |
|
|
||
|
IDS activity nmol/h/mg protein |
2 |
5 |
|
|
||
|
Prenatal diagnosis |
1st cousins |
1st cousins |
|
|
||
|
Age at diagnosis (year/month) |
3 years |
3 years |
|
|
||
|
Age of onset (year/month) |
18 months |
18 months |
|
|
||
|
Sex |
Male |
Male |
|
|
||
|
Growth retardation |
Marked |
Marked |
|
|
||
|
Macroglossia |
Marked |
Marked |
|
|
||
|
Macrocarinia |
Marked |
Marked |
|
|
||
|
Hepatosplenomegaly |
Marked |
Marked |
|
|
||
|
skeletal deformities |
severe |
severe |
|
|
||
|
Other features |
teeth small and poorly located deafness |
teeth small and poorly located deafness |
|
|
||
|
Mental retardation |
severe |
severe |
|
|
||
|
IDS activity nmol/h/mg protein |
2 |
5 |
|
|
||
|
Chkioua et al. Diagnostic Pathology 2011 6:42 doi:10.1186/1746-1596-6-42 |
||